A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)
Clinical trial NCT07141004 · RECRUITING
Trial details
- NCT number
- NCT07141004
- Sponsor
- Johnson & Johnson Private Limited
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-12
- Primary completion
- 2027-06-05
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.